These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 18849711)

  • 1. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reevaluation of the procedures used to perform thyroid bioassay on nuclear medicine personnel following radioiodine handling procedures.
    Lorah B; King S; Achey B
    Health Phys; 2012 May; 102(5 Suppl 2):S60-2. PubMed ID: 22470001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers.
    Vidal MV; Dantas AL; Dantas BM
    Radiat Prot Dosimetry; 2007; 125(1-4):483-7. PubMed ID: 17766259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques.
    Lucena EA; Rebelo AM; Araújo F; Sousa WO; Dantas AL; Dantas BM; Corbo R
    Radiat Prot Dosimetry; 2007; 127(1-4):465-8. PubMed ID: 17681960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
    Marcus CS; Siegel JA
    J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of ICRP 60 and the patient directive 97/43 Euratom for nuclear medicine.
    Bourguignon MH
    Q J Nucl Med; 2000 Dec; 44(4):301-9. PubMed ID: 11302257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRC inspections: risk-informed and performance-based.
    Beardsley MR
    J Nucl Med Technol; 2008 Sep; 36(3):129-31; quiz 144. PubMed ID: 18703617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hand exposure of nuclear medicine workers during administration of radioiodine.
    Wrzesien M; Olszewski J
    Radiat Prot Dosimetry; 2012 Aug; 151(1):147-52. PubMed ID: 22147924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor corrections, clarifying changes, and a minor policy change--NRC. Final rule.
    Fed Regist; 1998 Jul; 63(141):39477-83. PubMed ID: 10181512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of an environmental background level of 90Sr in urine for the Hanford bioassay program.
    Antonio CL; Rivard JW
    Health Phys; 2009 Nov; 97(5 Suppl):S180-2. PubMed ID: 19820473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic reference levels for medical exposure of patients: ICRP guidance and related ICRU quantities.
    Rosenstein M
    Health Phys; 2008 Nov; 95(5):528-34. PubMed ID: 18849685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of standards of protection for pregnant workers and their offspring.
    Suárez RC; Berard P; Harrison JD; Melo DR; Nosske D; Stabin M; Challeton-de Vathaire C
    Radiat Prot Dosimetry; 2007; 127(1-4):19-22. PubMed ID: 18079515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to technologists from preparing and administering therapeutic 131I: how frequently should we bioassay?
    Kopisch A; Martin CB; Grantham V
    J Nucl Med Technol; 2011 Mar; 39(1):60-2. PubMed ID: 21321250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for the release of individuals administered radioactive materials--NRC. Final rule.
    Fed Regist; 1997 Jan; 62(19):4120-33. PubMed ID: 10164806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finger doses for staff handling radiopharmaceuticals in nuclear medicine.
    Pant GS; Sharma SK; Rath GK
    J Nucl Med Technol; 2006 Sep; 34(3):169-73. PubMed ID: 16951286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
    Wellner U; Eschner W; Hillger HW; Schicha H
    Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Canadian National Calibration Reference Center for Bioassay and in Vivo Monitoring: an update.
    Daka JN; Kramer GH
    Health Phys; 2009 Dec; 97(6):590-4. PubMed ID: 19901593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational exposure in nuclear medicine in Portugal in the 1999-2003 period.
    Martins MB; Alves JG; Abrantes JN; Roda AR
    Radiat Prot Dosimetry; 2007; 125(1-4):130-4. PubMed ID: 17223645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation cataracts: new data and new recommendations.
    Frey GD
    AJR Am J Roentgenol; 2014 Oct; 203(4):W345-6. PubMed ID: 25247963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
    Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.